
Bill Anderson, Bayer CEO (Photo by Dia Dipasupil/Getty Images)
Bayer cautions pharma sales dip this year despite major upcoming launches
Bayer said Wednesday its pharmaceuticals unit will likely see a decline in sales in 2025, as the company reported another set of lackluster earnings amid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.